Aspirin and Lung Cancer Risk in Women
Author Information
Author(s): Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Koenig K L, Shore R E
Primary Institution: New York University School of Medicine
Hypothesis
Is regular aspirin use associated with a reduced risk of lung cancer in women?
Conclusion
The study suggests that regular aspirin use may be inversely associated with lung cancer risk in women, especially for non-small cell lung cancer.
Supporting Evidence
- Regular aspirin use for at least 6 months was associated with a lower risk of lung cancer.
- The odds ratio for lung cancer among women who used aspirin regularly was 0.66.
- A stronger inverse association was found for non-small cell lung cancer with an odds ratio of 0.39.
- Short-term aspirin use did not show a significant effect on lung cancer risk.
Takeaway
Taking aspirin regularly might help lower the chances of getting lung cancer in women.
Methodology
A case-control study nested in the NYU Women's Health Study, comparing aspirin use among lung cancer cases and matched controls.
Potential Biases
Recall and survival biases may affect the results, as some participants reported aspirin use after their diagnosis.
Limitations
The study had a small number of lung cancer cases and relied on self-reported aspirin use, which may introduce bias.
Participant Demographics
The study included mostly Caucasian women aged 31 to 70 years.
Statistical Information
P-Value
0.02
Confidence Interval
0.34–1.28
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website